| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Randomized trials stopped early for benefit: a systematic review.
|
JAMA
|
2005
|
8.43
|
|
2
|
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.
|
JAMA
|
2010
|
5.90
|
|
3
|
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
|
AIDS
|
2010
|
5.85
|
|
4
|
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
|
Ann Intern Med
|
2011
|
5.35
|
|
5
|
Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
|
JAMA
|
2009
|
5.34
|
|
6
|
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.
|
BMJ
|
2013
|
5.08
|
|
7
|
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
|
Arch Intern Med
|
2008
|
4.66
|
|
8
|
Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data.
|
Lancet
|
2008
|
4.33
|
|
9
|
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials.
|
Arch Intern Med
|
2006
|
4.19
|
|
10
|
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis.
|
BMJ
|
2009
|
3.39
|
|
11
|
Meta-analysis: accuracy of rapid tests for malaria in travelers returning from endemic areas.
|
Ann Intern Med
|
2005
|
3.08
|
|
12
|
Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study.
|
J Acquir Immune Defic Syndr
|
2013
|
3.02
|
|
13
|
Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
|
Circulation
|
2008
|
2.57
|
|
14
|
Effect of different antilipidemic agents and diets on mortality: a systematic review.
|
Arch Intern Med
|
2005
|
2.55
|
|
15
|
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
|
AIDS
|
2009
|
2.50
|
|
16
|
Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials.
|
JAMA
|
2006
|
2.38
|
|
17
|
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.
|
Clin Infect Dis
|
2005
|
2.35
|
|
18
|
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
|
Cochrane Database Syst Rev
|
2012
|
2.31
|
|
19
|
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
|
Evid Based Child Health
|
2013
|
2.12
|
|
20
|
Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.
|
Clin Infect Dis
|
2004
|
2.08
|
|
21
|
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.
|
BMJ
|
2007
|
2.07
|
|
22
|
Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation.
|
World J Surg
|
2015
|
1.95
|
|
23
|
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2006
|
1.95
|
|
24
|
Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors.
|
Am J Med
|
2011
|
1.87
|
|
25
|
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.
|
Antivir Ther
|
2008
|
1.83
|
|
26
|
Transient ischemic attack versus transient ischemic attack mimics: frequency, clinical characteristics and outcome.
|
Cerebrovasc Dis
|
2011
|
1.82
|
|
27
|
Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials.
|
Am J Med
|
2004
|
1.79
|
|
28
|
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2010
|
1.75
|
|
29
|
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2003
|
1.70
|
|
30
|
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
|
Clin Infect Dis
|
2012
|
1.67
|
|
31
|
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007.
|
AIDS
|
2011
|
1.65
|
|
32
|
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
|
PLoS Med
|
2010
|
1.65
|
|
33
|
An internationally generalizable risk index for mortality after one year of antiretroviral therapy.
|
AIDS
|
2013
|
1.64
|
|
34
|
Effectiveness of distant healing for patients with chronic fatigue syndrome: a randomised controlled partially blinded trial (EUHEALS).
|
Psychother Psychosom
|
2008
|
1.58
|
|
35
|
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
|
Antivir Ther
|
2007
|
1.55
|
|
36
|
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
|
Clin Infect Dis
|
2010
|
1.54
|
|
37
|
San Francisco Syncope Rule to predict short-term serious outcomes: a systematic review.
|
CMAJ
|
2011
|
1.48
|
|
38
|
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
|
Clin Chem Lab Med
|
2015
|
1.48
|
|
39
|
Numbers needed to treat derived from meta-analysis: a word of caution.
|
ACP J Club
|
2003
|
1.46
|
|
40
|
Assessing work ability--a cross-sectional study of interrater agreement between disability claimants, treating physicians, and medical experts.
|
Scand J Work Environ Health
|
2014
|
1.45
|
|
41
|
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.
|
AIDS
|
2012
|
1.42
|
|
42
|
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort.
|
AIDS
|
2002
|
1.41
|
|
43
|
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland.
|
AIDS
|
2015
|
1.41
|
|
44
|
Patient-reported respiratory symptoms and pre-bronchodilator airflow limitation among smokers in Switzerland.
|
Prim Care Respir J
|
2010
|
1.39
|
|
45
|
Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.
|
PLoS One
|
2011
|
1.38
|
|
46
|
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.
|
Antivir Ther
|
2005
|
1.36
|
|
47
|
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.
|
Antivir Ther
|
2008
|
1.29
|
|
48
|
A smoking cessation programme in HIV-infected individuals: a pilot study.
|
Antivir Ther
|
2006
|
1.27
|
|
49
|
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
|
Clin Infect Dis
|
2012
|
1.25
|
|
50
|
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study.
|
PLoS One
|
2012
|
1.25
|
|
51
|
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
|
Clin Infect Dis
|
2014
|
1.25
|
|
52
|
Association between ambient air pollution and diabetes mellitus in Europe and North America: systematic review and meta-analysis.
|
Environ Health Perspect
|
2015
|
1.24
|
|
53
|
Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution.
|
BMJ
|
2004
|
1.18
|
|
54
|
Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.
|
Crit Care
|
2010
|
1.17
|
|
55
|
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
|
PLoS One
|
2011
|
1.15
|
|
56
|
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
|
Antivir Ther
|
2008
|
1.14
|
|
57
|
CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era.
|
AIDS
|
2010
|
1.14
|
|
58
|
Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
|
BMC Health Serv Res
|
2007
|
1.14
|
|
59
|
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
|
AIDS
|
2012
|
1.11
|
|
60
|
The effect of antiretroviral treatment of different durations in primary HIV infection.
|
AIDS
|
2008
|
1.11
|
|
61
|
Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies.
|
Arch Intern Med
|
2006
|
1.10
|
|
62
|
Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study).
|
BMC Med Res Methodol
|
2012
|
1.10
|
|
63
|
Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study.
|
Ann Intern Med
|
2012
|
1.10
|
|
64
|
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.
|
Clin Infect Dis
|
2012
|
1.09
|
|
65
|
Communication training and antibiotic use in acute respiratory tract infections. A cluster randomised controlled trial in general practice.
|
Swiss Med Wkly
|
2006
|
1.08
|
|
66
|
Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study.
|
Ann Surg
|
2015
|
1.06
|
|
67
|
Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.
|
BMJ
|
2014
|
1.03
|
|
68
|
Validity of the Framingham point scores in the elderly: results from the Rotterdam study.
|
Am Heart J
|
2007
|
1.03
|
|
69
|
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.
|
Antivir Ther
|
2009
|
1.03
|
|
70
|
Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.
|
AIDS
|
2011
|
1.01
|
|
71
|
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
|
Antivir Ther
|
2007
|
0.99
|
|
72
|
Determinants of knowledge gain in evidence-based medicine short courses: an international assessment.
|
Open Med
|
2010
|
0.98
|
|
73
|
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671].
|
BMC Fam Pract
|
2005
|
0.98
|
|
74
|
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.
|
AIDS
|
2015
|
0.95
|
|
75
|
Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
|
Am J Med
|
2004
|
0.95
|
|
76
|
Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
|
PLoS One
|
2010
|
0.95
|
|
77
|
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.
|
PLoS One
|
2013
|
0.95
|
|
78
|
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
|
BMJ
|
2004
|
0.93
|
|
79
|
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV.
|
Antivir Ther
|
2009
|
0.92
|
|
80
|
Productivity costs and determinants of productivity in HIV-infected patients.
|
Clin Ther
|
2004
|
0.92
|
|
81
|
Is unsafe sexual behaviour increasing among HIV-infected individuals?
|
AIDS
|
2004
|
0.91
|
|
82
|
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.
|
Eur J Epidemiol
|
2013
|
0.91
|
|
83
|
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
|
Antivir Ther
|
2007
|
0.91
|
|
84
|
Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
|
Trials
|
2009
|
0.89
|
|
85
|
Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial.
|
J Vasc Surg
|
2008
|
0.89
|
|
86
|
Cost-effectiveness of drug-eluting stents in a US Medicare setting:a cost-utility analysis with 3-year clinical follow-up data.
|
Value Health
|
2011
|
0.87
|
|
87
|
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children.
|
Arch Dis Child
|
2010
|
0.87
|
|
88
|
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2015
|
0.87
|
|
89
|
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study.
|
AIDS
|
2004
|
0.87
|
|
90
|
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures.
|
J Acquir Immune Defic Syndr
|
2010
|
0.87
|
|
91
|
Statins for acute coronary syndrome.
|
Cochrane Database Syst Rev
|
2014
|
0.87
|
|
92
|
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
|
PLoS One
|
2012
|
0.87
|
|
93
|
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection.
|
Cochrane Database Syst Rev
|
2015
|
0.86
|
|
94
|
Statins for acute coronary syndrome.
|
Cochrane Database Syst Rev
|
2011
|
0.86
|
|
95
|
Propofol sedation alone or in combination with pharyngeal lidocaine anesthesia for routine upper GI endoscopy: a randomized, double-blind, placebo-controlled, non-inferiority trial.
|
Gastrointest Endosc
|
2011
|
0.85
|
|
96
|
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
|
Clin Infect Dis
|
2013
|
0.85
|
|
97
|
2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
|
JAMA
|
2010
|
0.85
|
|
98
|
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials.
|
BMC Infect Dis
|
2005
|
0.85
|
|
99
|
Shared-decision making in general practice: do patients with respiratory tract infections actually want it?
|
Swiss Med Wkly
|
2007
|
0.84
|
|
100
|
Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland.
|
BMC Med Inform Decis Mak
|
2008
|
0.84
|
|
101
|
Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis.
|
HIV Clin Trials
|
2015
|
0.84
|
|
102
|
Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients.
|
Int J Cardiol
|
2011
|
0.83
|
|
103
|
Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
|
PLoS One
|
2013
|
0.83
|
|
104
|
Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease. A meta-analysis of randomized controlled trials.
|
Eur Heart J
|
2004
|
0.83
|
|
105
|
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
|
Antivir Ther
|
2005
|
0.81
|
|
106
|
Intravenous opiate maintenance in a cohort of injecting drug addicts.
|
Drug Alcohol Depend
|
2003
|
0.81
|
|
107
|
Rosuvastatin in patients with elevated C-reactive protein.
|
N Engl J Med
|
2009
|
0.81
|
|
108
|
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study.
|
Crit Care Med
|
2016
|
0.80
|
|
109
|
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
|
AIDS
|
2007
|
0.80
|
|
110
|
Reporting of adverse events in surgical trials: critical appraisal of current practice.
|
World J Surg
|
2015
|
0.80
|
|
111
|
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS).
|
J Acquir Immune Defic Syndr
|
2013
|
0.79
|
|
112
|
CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysis.
|
Antivir Ther
|
2013
|
0.79
|
|
113
|
Inflammatory bowel perforation during immune restoration after one year of antiretroviral and antituberculous therapy in an HIV-1-infected patient: report of a case.
|
Dis Colon Rectum
|
2002
|
0.79
|
|
114
|
Prevalence and influence of diagnostic tests for acute respiratory tract infections in primary care.
|
Swiss Med Wkly
|
2006
|
0.79
|
|
115
|
Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy?
|
AIDS
|
2010
|
0.78
|
|
116
|
Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: update on recent trials and metaanalyses.
|
Curr Opin Lipidol
|
2005
|
0.78
|
|
117
|
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy.
|
AIDS
|
2005
|
0.78
|
|
118
|
Sexual risk behavior in HIV-infected injection drug users.
|
Clin Infect Dis
|
2004
|
0.78
|
|
119
|
Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients.
|
PLoS One
|
2013
|
0.78
|
|
120
|
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.
|
J Transl Med
|
2011
|
0.78
|
|
121
|
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.
|
J Acquir Immune Defic Syndr
|
2016
|
0.78
|
|
122
|
Patients' expectations about the benefit of antibiotic treatment: lessons from a randomised controlled trial.
|
Forsch Komplementarmed Klass Naturheilkd
|
2005
|
0.77
|
|
123
|
When time is more than money: the allocation of time between work and leisure in HIV-infected patients.
|
Soc Sci Med
|
2007
|
0.77
|
|
124
|
Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial.
|
PLoS One
|
2013
|
0.77
|
|
125
|
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study.
|
Antivir Ther
|
2012
|
0.77
|
|
126
|
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
|
J Clin Epidemiol
|
2008
|
0.77
|
|
127
|
Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective.
|
Swiss Med Wkly
|
2004
|
0.76
|
|
128
|
Infections requiring hospitalization of injection drug users who participated in an injection opiate maintenance program.
|
Clin Infect Dis
|
2002
|
0.76
|
|
129
|
The Use of Systematic Reviews When Designing and Reporting Surgical Trials.
|
Ann Surg
|
2017
|
0.75
|
|
130
|
Virological blips and predictors of post treatment viral control after stopping ART started in Primary HIV infection.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
131
|
Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
132
|
Two versus three-class antiretroviral therapy in antiretroviral-naive patients in different time periods of the HAART era.
|
AIDS
|
2007
|
0.75
|
|
133
|
Response by authors.
|
Evid Based Child Health
|
2013
|
0.75
|
|
134
|
Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort study.
|
Clin Chem Lab Med
|
2016
|
0.75
|
|
135
|
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
136
|
Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries.
|
Expert Opin Investig Drugs
|
2002
|
0.75
|
|
137
|
Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study.
|
AIDS
|
2017
|
0.75
|
|
138
|
Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
|
AIDS
|
2017
|
0.75
|
|
139
|
[Lung cancer screening - an overview about chances and risks].
|
Ther Umsch
|
2013
|
0.75
|
|
140
|
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
|
Cochrane Database Syst Rev
|
2017
|
0.75
|
|
141
|
Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids.
|
Swiss Med Wkly
|
2002
|
0.75
|
|
142
|
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.
|
HIV Clin Trials
|
2007
|
0.75
|